Trial · NCT01589237
Adverse events816
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 816
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | Part A-placebo of Pradigastat (LCQ908) Regimen | 1 | 11 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Part A-20mg Pradigastat (LCQ908) Regimen | 1 | 12 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Part A-40mg Pradigastat (LCQ908) Regimen | 0 | 10 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Part A: Pradigastat (LCQ908) Regimen- From Study A2212 | 1 | 5 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Part B-placebo of Pradigastat (LCQ908) Regimen | 0 | 5 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Part B-20mg Pradigastat (LCQ908) Regimen | 0 | 6 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Part B- Pradigastat (LCQ908) Regimen- From Study A2212 | 0 | 4 | |
| other | ANAEMIA | Blood and lymphatic system disorders | Part B-40 mg Pradigastat (LCQ908) | 0 | 4 | |
| other | CARDIAC FAILURE | Cardiac disorders | Part A-placebo of Pradigastat (LCQ908) Regimen | 0 | 11 | |
| other | CARDIAC FAILURE | Cardiac disorders | Part A-20mg Pradigastat (LCQ908) Regimen | 1 | 12 | |
| other | CARDIAC FAILURE | Cardiac disorders | Part A-40mg Pradigastat (LCQ908) Regimen | 0 | 10 | |
| other | CARDIAC FAILURE | Cardiac disorders | Part A: Pradigastat (LCQ908) Regimen- From Study A2212 | 0 | 5 | |
| other | CARDIAC FAILURE | Cardiac disorders | Part B-placebo of Pradigastat (LCQ908) Regimen | 0 | 5 | |
| other | CARDIAC FAILURE | Cardiac disorders | Part B-20mg Pradigastat (LCQ908) Regimen | 0 | 6 | |
| other | CARDIAC FAILURE | Cardiac disorders | Part B- Pradigastat (LCQ908) Regimen- From Study A2212 | 0 | 4 | |
| other | CARDIAC FAILURE | Cardiac disorders | Part B-40 mg Pradigastat (LCQ908) | 0 | 4 | |
| other | ABNORMAL PALMAR/PLANTAR CREASES | Congenital, familial and genetic disorders | Part A-placebo of Pradigastat (LCQ908) Regimen | 0 | 11 | |
| other | ABNORMAL PALMAR/PLANTAR CREASES | Congenital, familial and genetic disorders | Part A-20mg Pradigastat (LCQ908) Regimen | 0 | 12 | |
| other | ABNORMAL PALMAR/PLANTAR CREASES | Congenital, familial and genetic disorders | Part A-40mg Pradigastat (LCQ908) Regimen | 0 | 10 | |
| other | ABNORMAL PALMAR/PLANTAR CREASES | Congenital, familial and genetic disorders | Part A: Pradigastat (LCQ908) Regimen- From Study A2212 | 0 | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01589237/events